Traditionally, drug therapy to prevent or treat CVD has focused on individual risk factors. However, treating individual risk factors in isolation is suboptimal for CVD prevention and treatment. Managing multiple CV risks with multifaceted therapy aimed at global CV health is an essential component of the management paradigm